A detailed history of Surevest, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Surevest, LLC holds 140 shares of ABT stock, worth $15,876. This represents 0.0% of its overall portfolio holdings.

Number of Shares
140
Previous 183 23.5%
Holding current value
$15,876
Previous $20,000 30.0%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $4,160 - $4,817
-43 Reduced 23.5%
140 $14,000
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $1,531 - $1,850
15 Added 8.93%
183 $20,000
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $19,409 - $23,765
168 New
168 $24,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Surevest, LLC Portfolio

Follow Surevest, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Surevest, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Surevest, LLC with notifications on news.